Outcomes of Patients Not Responding to Oral Macrolide or B-lactam Therapy for the Treatment of Community-Acquired Pneumonia Due to Streptococcus Pneumoniae

Grants and Contracts Details

StatusFinished
Effective start/end date6/22/04 → 4/30/05

Funding

  • Aventis Pharmaceuticals Products Inc: $2.00